TransCode Therapeutics
RNAZ1.6303.82% ( +0.060 )
交易中: 10月5日 09:46:57 (美東)全部股東
股東類型
- 私人企業85.26%
- 公眾及其他12.20%
- 個人與內幕人士2.03%
- 機構投資者0.52%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
DEFJ, LLC | 83.48% | 1,413.45 萬 | 75.25% | +1,405.12 萬 | |
Unleash Immuno Oncolytics, Inc. | 1.77% | 30.00 萬 | -- | +30.00 萬 | 23/07/2026 |
Elena Braci | 1.10% | 18.62 萬 | -- | +18.62 萬 | 23/07/2026 |
Daniel Katzman | 0.92% | 15.56 萬 | -- | +15.56 萬 | 23/07/2026 |
Sabby Management, LLC | 0.25% | 4.16 萬 | 4.29% | +0 | 31/12/2025 |
Yorkville Advisors Global LP | 0.12% | 1.96 萬 | -- | +1.96 萬 | 30/06/2026 |
Geode Capital Management, LLC | 0.08% | 1.27 萬 | 1.31% | +0 | 31/03/2026 |
Vanguard Capital Management, LLC | 0.06% | 9,527.00 | 0.98% | +0 | 30/06/2026 |
UBS Asset Management AG | 0.02% | 2,888.00 | 0.89% | -5,407.00 | 30/06/2026 |
Thomas Tracy | <0.01% | 1,250.00 | 0.13% | +0 | |
Strategic Advisers LLC | <0.01% | 706.00 | -- | +706.00 | 30/06/2026 |
Tower Research Capital Europe Limited | <0.01% | 677.00 | 0.02% | +449.00 | 30/06/2026 |
The Goldman Sachs Group, Inc. | <0.01% | 82.00 | <0.01% | +0 | 30/09/2025 |
Wells Fargo & Company | <0.01% | 55.00 | <0.01% | +0 | 30/06/2026 |
SBI Holdings, Inc. | <0.01% | 12.00 | <0.01% | +0 | 30/06/2026 |
Thomas FitzgeraldFormer CFO, Secretary, President, VP of Administration & Director | <0.01% | 3.00 | <0.01% | +1.00 | 28/05/2026 |
Philippe CalaisCEO & Executive Chairman of the Board | <0.01% | 2.00 | <0.01% | +1.00 | 28/05/2026 |
Erik MantingIndependent Director | 0.00% | 0.00 | 0.00% | +0 | 28/05/2026 |
RBC Dominion Securities Inc. | 0.00% | 0.00 | <0.01% | -8.00 | 30/06/2026 |
Magda MarquetIndependent Director | 0.00% | 0.00 | 0.00% | +0 | 28/05/2026 |